Drug Chatter -- Tracking biopharma stock chatter

Profile for Ardelyx, Inc. (ARDX)

« Back to company index

ARDX Chatter Timeline

Stock Ticker for ARDX

Most Active Tweeters for ARDX

UserTweets
@windham_kathryn 4
@noritsunagirota 3
@TheMarketsDaily 2
@tymorapro 2
@harveyrosenblum 2

Recent Tweets for ARDX

MarieSm76375904 @MarieSm76375904
Analysts See $-0.39 EPS for Ardelyx, Inc. $ARDX https://t.co/XlFHSbP6KP
January 15th 2018, 12:01pm
noritsunagirota @noritsunagirota
Deerfield Management Company Has Boosted Its Ardelyx $ARDX Position https://t.co/dEVm4FmFkG
January 14th 2018, 11:01am
windham_kathryn @windham_kathryn
Ardelyx, Inc. $ARDX Analysts See $-0.39 EPS https://t.co/exRLVbdvJJ
January 14th 2018, 11:01am
noritsunagirota @noritsunagirota
Analysts See $-0.39 EPS for Ardelyx, Inc. $ARDX https://t.co/PXfxlGXFqd
January 13th 2018, 11:01am
OlympiaReport @OlympiaReport
Ardelyx $ARDX Given Daily Media Sentiment Rating of 0.14 https://t.co/k4KJJdd2af
January 13th 2018, 8:01am
MariaDa18810214 @MariaDa18810214
As Ardelyx $ARDX Stock Value Declined, Cormorant Asset Management Has Trimmed Position by $4.25 Million ...
January 10th 2018, 2:01pm
windham_kathryn @windham_kathryn
Ardelyx, Inc. $ARDX Reaches $7.03 After 8.00% Up Move https://t.co/xoWOrfmYb5
January 9th 2018, 1:01pm
ChartMill @ChartMill
An Altman-Z score of 8.03 indicates that $ARDX is not in any danger for bankruptcy at the moment.… https://t.co/GsjYbgP1UJ
January 8th 2018, 1:01pm
tymorapro @tymorapro
$ARDX: At/Below PivotS4[6.78],200DaySMA 3Mo50%R[6.70]:3d, lm:-4, 4NearLo, AtPivS4, 9:3Accel-, allTFs+, ch:-5.5%, medFlt:28M, HiPctSht[8%:6d]
January 8th 2018, 10:01am
TheMarketsDaily @TheMarketsDaily
Ardelyx $ARDX Given Daily News Sentiment Rating of 0.11 https://t.co/NpYsp97LW7
January 8th 2018, 9:01am
wosaikeneriki @wosaikeneriki
As Ardelyx $ARDX Valuation Declined, Cormorant Asset Management Has Trimmed Its Position ...
January 6th 2018, 12:01pm
jknapp1993 @jknapp1993
#madtweets what's with analysts predicting $12 on $ardx? Company has no revenue.
January 5th 2018, 6:01pm
TranscriptDaily @TranscriptDaily
Ardelyx $ARDX Given a $12.00 Price Target by Cantor Fitzgerald Analysts https://t.co/msSOciZAPl
January 5th 2018, 11:01am
TribuneTrueBlue @TribuneTrueBlue
Ardelyx $ARDX Given a $12.00 Price Target by Cantor Fitzgerald Analysts https://t.co/XQFLQ0I2ZE
January 5th 2018, 11:01am
AmericanBanking @AmericanBanking
Ardelyx Inc $ARDX Receives Consensus Rating of “Buy” from Brokerages https://t.co/cEAYNJ7KGi #stocks
January 5th 2018, 8:01am
ledgerzette @ledgerzette
Ardelyx $ARDX Given a $12.00 Price Target at Cantor Fitzgerald https://t.co/2EcrrUkfN0
January 4th 2018, 11:01pm
newswelldone @newswelldone
$ARDX: Can The Uptrend Continue for Ardelyx (ARDX)? January 04, 2018: https://t.co/tKoaqpujDY
January 4th 2018, 4:01am
stocknewsdotcom @stocknewsdotcom
$ARDX Cantor Fitzgerald sets PT at $12 https://t.co/VZt0Dfu1EF
January 3rd 2018, 7:01pm
pennyomegaCRWE @pennyomegaCRWE
$ARDX Reveals findings from late-stage study evaluating tenapanor for the treatment of IBS-C patients https://t.co/ZeT16B4rfE
January 3rd 2018, 4:01pm
MaisaCorp @MaisaCorp
$ARDX completes T3MPO-3 safety extension study of Tenapanor for IBS-C
January 3rd 2018, 4:01pm
noritsunagirota @noritsunagirota
Deerfield Management Company Has Increased Ardelyx $ARDX Position by $2.33 Million https://t.co/fxTqN5WXzn
January 3rd 2018, 10:01am
whotrades @whotrades
Ardelyx completes safety extension portion of Phase 3 T3MPO program $ARDX https://t.co/fYG1uaO9eB https://t.co/67X7m6D8YB
January 3rd 2018, 9:01am
SwingTradeBot @SwingTradeBot
Recent $ARDX technical alerts: 180 Bullish Setup plus 3 more alerts... https://t.co/MkyIIZeECq
January 3rd 2018, 9:01am
UdallTechStrat @UdallTechStrat
$ARDX been a nice quiet mover but now +35-40% from prior Tweets
January 3rd 2018, 9:01am
Hypocrites_Oath @Hypocrites_Oath
RT @OpenOutcrier: $ARDX (+6.4% pre) Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C - PRN https://t.c…
January 3rd 2018, 8:01am
TheMarketsDaily @TheMarketsDaily
Somewhat Positive News Coverage Somewhat Unlikely to Impact Ardelyx $ARDX Share Price https://t.co/KDmnJmz0sq
January 3rd 2018, 8:01am
OpenOutcrier @OpenOutcrier
$ARDX (+6.4% pre) Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C - PRN https://t.co/32bZEdM5b4
January 3rd 2018, 8:01am
OLEGEFF @OLEGEFF
Ardelyx completes T3MPO-3 safety extension study of Tenapanor for IBS-C https://t.co/ew6WUaAm5f $ARDX
January 3rd 2018, 7:01am
ProVesting @ProVesting
$ARDX: Ardelyx completes T3MPO-3 safety extension study of Tenapanor for …: https://t.co/39dMPOk9WE
January 3rd 2018, 7:01am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Ardelyx completes T3MPO-3 safety extension study of Tenapanor for IBS-C https://t.co/4yi6KAh3Tl #premarket $ARDX
January 3rd 2018, 7:01am
MarketCurrents @MarketCurrents
Ardelyx completes T3MPO-3 safety extension study of Tenapanor for IBS-C https://t.co/MzAmHfPK3L #premarket $ARDX
January 3rd 2018, 7:01am
1MinuteStock @1MinuteStock
Unicorn Bay rating for $ARDX is 2.82 out of 5. https://t.co/2RSgBzPuVR
January 3rd 2018, 7:01am
n_yigitbasi @n_yigitbasi
$ARDX Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C
January 3rd 2018, 7:01am
jonnajarian @jonnajarian
$ARDX completed safety extension portion of its Phase 3 for the treatment of patients with irritable bowel syndrome… https://t.co/tQCX54jzYs
January 3rd 2018, 7:01am
NewsQuantified @NewsQuantified
$ARDX after it completes safety extension portion of Phase 3 #T3MPO program, stocks rise +5.71%, #Ardelyx https://t.co/4YJyW8ZtDR
January 3rd 2018, 7:01am
efinancialpub @efinancialpub
RT @ProTradersNews: $ARDX: Ardelyx (ARDX) Reports Positive Results of T3MPO-3 Safety …: https://t.co/UtLMsSa85B
January 3rd 2018, 6:01am
NAS_TAQZ @NAS_TAQZ
$ARDX Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C ??
January 3rd 2018, 6:01am
ProTradersNews @ProTradersNews
$ARDX: Ardelyx (ARDX) Reports Positive Results of T3MPO-3 Safety …: https://t.co/UtLMsSa85B
January 3rd 2018, 6:01am
biostockinfo @biostockinfo
RT @BioStocks: $ARDX Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C https://t.co/T4NAbn98og
January 3rd 2018, 6:01am
newswithvalue @newswithvalue
$ARDX: Ardelyx Announces Presentation at JP Morgan 36th Annual …: https://t.co/rp7xpk1gfM
January 3rd 2018, 6:01am
NewsToDesk @NewsToDesk
$ARDX: Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of …: https://t.co/rzJ1ou1dtC
January 3rd 2018, 6:01am
FonsieTrader @FonsieTrader
$ARDX Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C https://t.co/A908hmoHaW
January 3rd 2018, 6:01am
portefeuillefun @portefeuillefun
RT @odibro: $ARDX Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C https://t.co/9eIcPZ3XeE
January 3rd 2018, 6:01am
stocknewsdotcom @stocknewsdotcom
$ARDX Completes T3MPO-3 safety extension study of Tenapanor for IBS-C https://t.co/uMwRoW9Aki
January 3rd 2018, 6:01am
BioStocks @BioStocks
$ARDX Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C https://t.co/T4NAbn98og
January 3rd 2018, 6:01am
odibro @odibro
$ARDX Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C https://t.co/9eIcPZ3XeE
January 3rd 2018, 6:01am
harveyrosenblum @harveyrosenblum
A reminder of $ARDX price action last time it crossed the 200d SMA in Sept 2016 ... 60-ish% Why do so many… https://t.co/gVdCIUNU1u
January 2nd 2018, 4:01pm
harveyrosenblum @harveyrosenblum
$ARDX All moving averages trending up, except 200 day SMA Close above 200 Day SMA likely today Calling all… https://t.co/oexXhWok4L
January 2nd 2018, 3:01pm
windham_kathryn @windham_kathryn
Cormorant Asset Management Has Lowered Its Ardelyx $ARDX Stake https://t.co/2dC5xyQocK
January 2nd 2018, 2:01pm
tymorapro @tymorapro
$ARDX: At/Below 200DaySMA[-6.90]:5M, lm:+3, 2NearHi:BrkPLo[+5.3%], allTFs+, ch:+4.5%, medFlt:28M, HiPctSht[8%:7d]; TLM:1.3; cl+op+
January 2nd 2018, 12:01pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.